ghk-cu low immunogenicity of peptide antibody formation or In Vitro and in Vivo Studies pH-Sensitive immunogenicity of ghk-cu immune response

It may be one of the first peptides shown to act as a selective gene expression modulator, without the off-target chaos of pharmacological epigenetic drugs

Pain or swelling at the injection site, itchiness, or diarrhea can occur

It can increase the rate of drug diffusion through the skin by more than four times

Always talk to a qualified healthcare professional before starting any research protocol

This stability has made the peptide a useful research tool in experimental models investigating peptide signaling under physiologically relevant biochemical conditions

At injury sites, it increases NO production to enhance blood flow and reduce platelet aggregation